HK1256146A1 - 溶瘤病毒作為用於治療腫瘤和/或癌症的免疫刺激劑的應用 - Google Patents

溶瘤病毒作為用於治療腫瘤和/或癌症的免疫刺激劑的應用

Info

Publication number
HK1256146A1
HK1256146A1 HK18115227.3A HK18115227A HK1256146A1 HK 1256146 A1 HK1256146 A1 HK 1256146A1 HK 18115227 A HK18115227 A HK 18115227A HK 1256146 A1 HK1256146 A1 HK 1256146A1
Authority
HK
Hong Kong
Prior art keywords
immunostimulant
tumors
cancer
treatment
application
Prior art date
Application number
HK18115227.3A
Other languages
English (en)
Inventor
趙榮華
鄭豔軍
胡放
Original Assignee
杭州康萬達醫藥科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 杭州康萬達醫藥科技有限公司 filed Critical 杭州康萬達醫藥科技有限公司
Priority to HK18115227.3A priority Critical patent/HK1256146A1/zh
Publication of HK1256146A1 publication Critical patent/HK1256146A1/zh

Links

HK18115227.3A 2018-11-28 2018-11-28 溶瘤病毒作為用於治療腫瘤和/或癌症的免疫刺激劑的應用 HK1256146A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18115227.3A HK1256146A1 (zh) 2018-11-28 2018-11-28 溶瘤病毒作為用於治療腫瘤和/或癌症的免疫刺激劑的應用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18115227.3A HK1256146A1 (zh) 2018-11-28 2018-11-28 溶瘤病毒作為用於治療腫瘤和/或癌症的免疫刺激劑的應用

Publications (1)

Publication Number Publication Date
HK1256146A1 true HK1256146A1 (zh) 2019-09-13

Family

ID=71603837

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18115227.3A HK1256146A1 (zh) 2018-11-28 2018-11-28 溶瘤病毒作為用於治療腫瘤和/或癌症的免疫刺激劑的應用

Country Status (1)

Country Link
HK (1) HK1256146A1 (zh)

Similar Documents

Publication Publication Date Title
HK1252873A1 (zh) 用於癌症治療和預防的疫苗
IL262385B1 (en) Structure of a recombinant herpes simplex virus-committed vector and constructs for cancer therapy
EP3454911A4 (en) ONCOLYTIC VIRUSES COMPRISING A GENE ESRAGE AND METHODS OF TREATING CANCER
EP3690034A4 (en) ISOLATED RECOMBINANT ONCOLYTIC SMALLPOX VIRUS, PHARMACEUTICAL COMPOSITION AND USES FOR TREATMENT OF TUMORS AND / OR CANCER
IL273196A (en) Claudin 6 antibodies and methods of cancer treatment
EP3134423A4 (en) 2' -disubstituted nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
IL275550A (en) Recombinant virus on a region reduced from optimal for a codon pair and its use for cancer treatment
EP3888648A4 (en) CANCER TREATMENT BY COMBINATION OF IMMUNE CHECKPOINT INHIBITOR AND FOLFIRINOX THERAPY
EP3411122A4 (en) CANCER VACCINES AND TREATMENT METHODS THEREWITH
IL281730A (en) Combinations of the virus and axinia oncolytic and checkpoint suppressors of the immune system for the treatment of cancer, and pharmaceutical preparations containing these combinations
IL280060A (en) Methods for treating cancer with TNF-expressing myxoma virus
IL275517A (en) Combined methods and treatment of cancer
EP3890777A4 (en) METHODS OF ACTIVATING DYSFUNCTIONAL IMMUNE CELLS AND CANCER TREATMENT
SG11202005296SA (en) Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
IL279591A (en) Cancer treatment methods using combination therapy
IL276203A (en) Compounds and methods for treating cancer
EP3875119A4 (en) ONCOLYTIC VIRUS FOR THE TREATMENT OF CANCER
EP3700551A4 (en) TUMOR VACCIN COMPOSITIONS AND METHODS OF USING THEM FOR THE TREATMENT OF CANCER
EP3560513A4 (en) ANTICANCER THERAPY USING A COMBINATION OF AN ORAL TUMOR VACCINE AND AN IMMUNOSUPPRESSION INHIBITOR
IL275913A (en) Methods and combined treatment for cancer treatment
EP3642335A4 (en) RECOMBINANT ONCOLYTIC VIRUSES FOR THE TREATMENT OF METASTATIC CANCER
IL285221A (en) Use of oncolytic viruses to treat cancer
HK1256146A1 (zh) 溶瘤病毒作為用於治療腫瘤和/或癌症的免疫刺激劑的應用
EP3490971A4 (en) METHOD FOR TREATING AND PREVENTING SIDE EFFECTS OF A CANCER TREATMENT
GB201816547D0 (en) Oncolytic virus for the treatment of cancer